【摘要】 目的探讨单一及联合药物化疗对老年胃癌患者(大于或等于70岁)的影响。方法 2009年1月至2014年10月河南省南阳市中心医院普外科120例住院老年胃癌患者采用随机数字表法分为单一药物化疗组(n=60)和联合药物化疗组(n=60),比较两组不良反应及生存时间。结果单一药物化疗组恶心、呕吐,腹泻、便秘、白细胞下降,口腔黏膜炎,周围神经炎的发生率低于联合化疗组,差异有统计学意义(P<0.05);单一药物化疗组血红蛋白下降、血小板下降、转氨酶升高的发生率低于联合药物化疗组,但差异无统计学意义(P>0.05)。联合药物化疗组患者生存时间较单一药物化疗组患者生存时间稍长,但二者比较,差异无统计学意义(P>0.05)。结论单一药物化疗治疗老年胃癌患者不良反应少且患者生存时间无明显缩短。更多还原

【Abstract】 Objective To investigate the influence of single agent and combined medication chemotherapy on elderly patients with gastric cancer.Methods One hundred and twenty elderly inpatients with gastric cancer in the general surgery department of the Nanyang Municipal Central Hospital from January 2009 to October 2014 were divided into the single agent chemotherapy group(n=60)and combined medication chemotherapy group(n=60).The adverse reactions and survival time were compared between the two groups.Results The occurrence rates of nausea,vomiting,diarrhea,constipation,leukopenia,oral mucositis and peripheral neuropathy in the single agent group were lower than those in the combined chemotherapy group,the difference between the two groups was statistically significant(P<0.05);the occurrence rates of Hb decrease,thrombocytopenia and transaminase elevation in the single agent group were lower than those in the combined chemotherapy group,but the difference was not statistically significant(P>0.05);the survival time in the combined chemotherapy group was longer than that in the single agent chemotherapy group,but the difference between them was not statistically significant(P>0.05).Conclusion Single agent chemotherapy may be considered as the first-line chemotherapy scheme for elderly patients with gastric cancer.更多还原